BioSpec Global Solutions president Don Saunders and Dr. Paul Yip to visit China in December
scheduled to depart for
response to the invitation sent to BioSpec from the Chinese government.
The trip will last ten days and meetings have been scheduled with
|December 13, arrive Guang Zhou P.M., pickup by Guang Dong Government.|
|reception dinner by local Government.|
|December 14., official welcome by Government, meet Government|
|officials from various division and departments ( Guangzhou Foshan ).|
business meeting, demo etc., Official reception dinner by the
|December 15, Tour Foshan, introductory Foshan business/industries,|
|meeting with officials about JV of the BioSpec. etc.,|
|December 15. Afternoon or Evening, go to Zhuhai and Macau, meet|
|another contact who has Macau, Korean & Japan market for BioSpec.|
|December 16. AM. Macau, medical products , back to Foshan PM,|
|reception by Foreign Affairs minister.|
|December 17. Foshan, attend government event.|
|December 18. Fly to Shanghai, meet local government and business|
|December 19. AM. Demo, meeting, PM fly to Beijing|
|December 20. Meeting with Government officials, demo, business|
|December 21. Meeting with China J/investor group, demo.|
|December 22. Depart from Beijing to Canada.|
“This trip will mark the beginning of the introduction of BioSpec’s
technology to the Chinese market”, said
BioSpec Global Solutions Inc.
BioSpec Global Solutions Inc., holds worldwide patents on the TOG’s 3000
and 9000 machines for rapid, onsite (remote) monitoring of microbial
contamination in drinking water, recreational water, agriculture &
food, pharmaceuticals and medical applications.
ICBS specializes in mergers and acquisitions (M&A) advisory services and
invests in selective businesses with potential for high growth.
New Boston Holding Group Inc., is an American company representing
Legal Notice Regarding Forward-Looking Statements: Safe Harbour: This
press release contains forward-looking information within the meaning
of section 27A of the Securities Act of 1933 and section 21E of the
Securities Exchange Act of 1934 and is subject to the Safe Harbour
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties
and other factors, which may cause the actual results, performance or
achievements of ICBS Limited, to be materially different from the
statements made herein.
SOURCE BioSpec Global Solutions Inc.